Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant in Hormone-refractory Prostate Cancer
NCT00476645Phase 2Completed
- Sponsor
- Stanford University
- Start
- Sep 2006
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in castration-resistant prostate cancer (CRPC), sponsored by Stanford University. Started Sep 2006; status: completed.
02
Drugs
fulvestrant
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT00476645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476645.